Literature DB >> 26230140

Imaging-Based Liver Function Tests--Past, Present and Future.

D Geisel1, L Lüdemann2, B Hamm1, T Denecke1.   

Abstract

UNLABELLED: Preoperative assessment of liver function and prediction of postoperative functional reserve are important in patients scheduled for liver resection. While determination of absolute liver function currently mostly relies on laboratory tests and clinical scores, postoperative remnant liver function is estimated volumetrically using imaging data obtained with computed tomography (CT) or magnetic resonance imaging (MRI). Accurate estimation of hepatic function is also relevant for intensive care patients, oncologic patients, and patients with diffuse liver disease. The indocyanine green (ICG) test is still the only established test for estimating true global liver function. However, more recent tools such as the LiMAx test also allow global assessment of hepatic function. These tests are limited when liver function is inhomogeneously distributed, which is the case in such conditions as unilateral cholestasis or after portal vein embolization. Imaging-based liver function tests were first developed in nuclear medicine and, compared with laboratory tests, have the advantage of displaying the spatial distribution of liver function. Nuclear medicine scans are obtained using tracers such as 99mTc galactosyl and 99mTc mebrofenin. Liver function is typically assessed using planar scintigraphy. However, three-dimensional volumetry is possible with single-photon emission computed tomography (SPECT-CT). Another technique for image-based liver function estimation is Gd-EOB-enhanced MRI. While metabolization of Gd-EOB in the body is similar to that of ICG and mebrofenin, its distribution in the liver can be displayed by MRI with higher temporal and spatial resolution. Moreover, MRI-based determination of liver function can be integrated into routine preoperative imaging. This makes MRI an ideal candidate for preoperative determination of liver function, though the best pulse sequence and the parameter to be derived from the image information remain to be identified. Another question to be answered is how the results may be affected by renal function and the presence of hyperbilirubinemia. As more results from clinical evaluation including comparison with postoperative liver function data become available, image-based liver function tests, especially with use of Gd-EOB as the contrast medium, have the potential to add another dimension to preoperative imaging. KEY POINTS: Liver function consists of a multitude of subfunctions such as biotransformation, excretion and storage. Global liver function tests are score-based tests such as Child-Pugh or MELD as well as the ICG- and LiMAx-test. Imaging-based liver function tests add spatial information. Current clinical standard is the 99mTc-Mebrofenin-scintigraphy. MRI-based function tests with Gd-EOB-DTPA have the potential to integrate seamlessly into clinical workup, feature a higher temporal and spatial resolution and do not rely on ionizing radiation. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26230140     DOI: 10.1055/s-0035-1553306

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  19 in total

Review 1.  [CT and MRI of the liver: when, what, why?]

Authors:  J Budjan; S O Schoenberg; U I Attenberger
Journal:  Radiologe       Date:  2017-05       Impact factor: 0.635

2.  Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.

Authors:  Mengqi Huang; Shunli Shen; Huasong Cai; Zhenpeng Peng; Wan Hang Keith Chiu; Zi-Ping Li; Baogang Peng; Shi-Ting Feng
Journal:  Eur Radiol       Date:  2021-01-15       Impact factor: 5.315

3.  Quantitative analysis of liver function: 3D variable-flip-angle versus Look-Locker T1 relaxometry in hepatocyte-specific contrast-enhanced liver MRI.

Authors:  Niklas Verloh; Irene Fuhrmann; Claudia Fellner; Dominik Nickel; Florian Zeman; Arne Kandulski; Matthias Hornung; Christian Stroszczynski; Philipp Wiggermann; Michael Haimerl
Journal:  Quant Imaging Med Surg       Date:  2022-04

4.  Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.

Authors:  Anthony D Nehlsen; Kunal K Sindhu; Thomas Wolken; Fahad Khan; Christopher K Kyriakakos; Stephen C Ward; Erin Moshier; Bachir Taouli; Michael Buckstein
Journal:  Radiol Imaging Cancer       Date:  2022-07

5.  Developments in diagnosis and management of post-liver transplantation biliary complications: the radiologist's perspective.

Authors:  Paolo Marra; Pietro Andrea Bonaffini; Davide Ippolito; Sandro Sironi
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

6.  Gd-EOB-DTPA-enhanced MRI for monitoring future liver remnant function after portal vein embolization and extended hemihepatectomy: A prospective trial.

Authors:  Dominik Geisel; Philip Raabe; Lutz Lüdemann; Maciej Malinowski; Martin Stockmann; Daniel Seehofer; Johann Pratschke; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2016-12-13       Impact factor: 5.315

7.  ALPPS for Hepatocellular Carcinoma Is Associated with Decreased Liver Remnant Growth.

Authors:  Daryl Kai Ann Chia; Zachery Yeo; Stanley Eu Kuang Loh; Shridhar Ganpathi Iyer; Krishnakumar Madhavan; Alfred Wei Chieh Kow
Journal:  J Gastrointest Surg       Date:  2018-01-29       Impact factor: 3.452

Review 8.  [Preoperative imaging/operation planning for liver surgery].

Authors:  W N Schoening; T Denecke; U P Neumann
Journal:  Chirurg       Date:  2015-12       Impact factor: 0.955

Review 9.  Hepatic metastasis from colorectal cancer.

Authors:  Alfred Wei Chieh Kow
Journal:  J Gastrointest Oncol       Date:  2019-12

Review 10.  ICG Clearance Test and 99mTc-GSA SPECT/CT Fusion Images.

Authors:  Yuji Iimuro
Journal:  Visc Med       Date:  2017-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.